Tag: THT 2026
THT 2026: HFrEF patients undergoing baroreflex activation therapy see shift in LVEF
Initial six-month outcomes from the REBALANCE registry, assessing baroreflex activation therapy with...
THT 2026: Autologous cell therapy may curb pathological ventricular remodelling in chronic ischaemic HFrEF patients
BioCardia has reported late-breaking echocardiography results from its phase III clinical trial ...
THT 2026: Study of smart implant for heart failure decongestion reports first-in-human data
Relief Cardiovascular has announced positive 90-day results from the prospective, multicentre RE...
